Literature DB >> 21660155

The kaiser permanente northwest cardiovascular risk factor management program: a model for all.

Jodi S Joyce, Martina M Fetter, Dean H Klopfenstein, Michael K Nash.   

Abstract

Proof of the effectiveness of preventive measures that reduce established risk traits for atherothrombotic disorders has spurred attempts to systematically apply these interventions among susceptible populations. One such attempt is the Cardiovascular Risk Factor Management (CVRFM) Program, launched in 2003 to optimize clinical management and outcomes for 75,000 Kaiser Permanente Northwest Region (KPNW) members with atherosclerotic cardiovascular disease (CVD) or hypertension. The CVRFM Program is a centralized, multidisciplinary, proactive telephone-based clinical management intervention consisting of an "outreach" call, an interview, a mailed individualized care plan and information packet, regular follow-up (including protocolized medication management) and-when "goal status" is achieved-transfer of the patient to a maintenance plan.Quarterly evaluation of effectiveness entailed measurement of a range of clinical, utilization, and member satisfaction outcomes. Results by the fourth quarter were outstanding: For example, >98% of participants with coronary disease or diabetes had LDL cholesterol testing, >90% of coronary patients received aspirin or statin treatment, 99% were "extremely" or "very" satisfied with the program, and reductions were observed in the number of hospitalizations and visits to the emergency department and clinic. Mathematical models predict a decrease in myocardial infarctions and cardiovascular mortality within two years after implementing the program, the underlying principles of which should yield similar improvement in other Kaiser Permanente (KP) Regions and in other health care organizations.

Entities:  

Year:  2005        PMID: 21660155      PMCID: PMC3104824          DOI: 10.7812/TPP/04-068

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  37 in total

1.  Physical fitness and activity as separate heart disease risk factors: a meta-analysis.

Authors:  P T Williams
Journal:  Med Sci Sports Exerc       Date:  2001-05       Impact factor: 5.411

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Systematic review on the risk and benefit of different cholesterol-lowering interventions.

Authors:  H C Bucher; L E Griffith; G H Guyatt
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-02       Impact factor: 8.311

4.  Impact of multiple risk factor profiles on determining cardiovascular disease risk.

Authors:  H R Yusuf; W H Giles; J B Croft; R F Anda; M L Casper
Journal:  Prev Med       Date:  1998 Jan-Feb       Impact factor: 4.018

5.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

6.  Public health burden of coronary heart disease risk factors among middle-aged and elderly men.

Authors:  N Haapanen-Niemi; I Vuori; M Pasanen
Journal:  Prev Med       Date:  1999-04       Impact factor: 4.018

7.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.

Authors:  Heiner C Bucher; Peter Hengstler; Christian Schindler; Gabriela Meier
Journal:  Am J Med       Date:  2002-03       Impact factor: 4.965

8.  Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention.

Authors:  S A Grover; S Paquet; C Levinton; L Coupal; H Zowall
Journal:  Arch Intern Med       Date:  1998-03-23

9.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group.

Authors: 
Journal:  Circulation       Date:  1998-06-09       Impact factor: 29.690

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.